Asterix Foods
Israel
- Tel Aviv
- 10/10/2025
- Seed
- $4,200,000
Industry leading companies like Impossible, Perfect Day (RebelBio), and EVERY (IndieBio) have shown the powerful commercial appeal of animal-free proteins. Behind this first wave comes a second wave: glycoproteins.
Glycoproteins require precise glycosylations to accurately fold, recognize, and bind – driving functional performance needed in the food industry. To unlock this second wave of animal-free proteins, Asterix Foods is using plant cells, because plant cells can easily achieve glycosylations that microbial fermentation is challenged by.
- Industry Biotechnology
- Website https://www.asterixfoods.com/
- LinkedIn https://www.linkedin.com/company/asterix-foods/
Related People
Dan EvenFounder
Israel -
Tel Aviv District
Experienced in Molecular Biology, Plant Genetic Engineering, and Plant Biology.
Specializing in: Research and Development, Biotechnology, Molecular Biology, Alternative Food & Protein, Plant Biology, Plant Genetic Engineering, Protein Purification & Expression, Antibody Engineering, Microbiology.
Valinor | $13,000,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
conveyd | $3,345,837 | (Dec 12, 2025)
Ritten | $35,000,000 | (Dec 12, 2025)
Safebooks AI | $15,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Yonda | $15,000,000 | (Dec 12, 2025)
Medra | $52,000,000 | (Dec 12, 2025)
Cynch AI | $9,000,000 | (Dec 12, 2025)
Empromptu.ai | $2,000,000 | (Dec 11, 2025)